BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24598806)

  • 1. A mutation in TRPC6 channels abolishes their activation by hypoosmotic stretch but does not affect activation by diacylglycerol or G protein signaling cascades.
    Wilson C; Dryer SE
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1018-25. PubMed ID: 24598806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
    Roshanravan H; Dryer SE
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1088-97. PubMed ID: 24553432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol.
    Anderson M; Kim EY; Hagmann H; Benzing T; Dryer SE
    Am J Physiol Cell Physiol; 2013 Aug; 305(3):C276-89. PubMed ID: 23657570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in TRPC3 and TRPC6 channels assembly in mesenteric vascular smooth muscle cells in essential hypertension.
    Álvarez-Miguel I; Cidad P; Pérez-García MT; López-López JR
    J Physiol; 2017 Mar; 595(5):1497-1513. PubMed ID: 27861908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic activation of vascular TRPC6 channel by receptor and mechanical stimulation via phospholipase C/diacylglycerol and phospholipase A2/omega-hydroxylase/20-HETE pathways.
    Inoue R; Jensen LJ; Jian Z; Shi J; Hai L; Lurie AI; Henriksen FH; Salomonsson M; Morita H; Kawarabayashi Y; Mori M; Mori Y; Ito Y
    Circ Res; 2009 Jun; 104(12):1399-409. PubMed ID: 19443836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOX2 interacts with podocyte TRPC6 channels and contributes to their activation by diacylglycerol: essential role of podocin in formation of this complex.
    Kim EY; Anderson M; Wilson C; Hagmann H; Benzing T; Dryer SE
    Am J Physiol Cell Physiol; 2013 Nov; 305(9):C960-71. PubMed ID: 23948707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New TRPC6 gain-of-function mutation in a non-consanguineous Dutch family with late-onset focal segmental glomerulosclerosis.
    Hofstra JM; Lainez S; van Kuijk WH; Schoots J; Baltissen MP; Hoefsloot LH; Knoers NV; Berden JH; Bindels RJ; van der Vlag J; Hoenderop JG; Wetzels JF; Nijenhuis T
    Nephrol Dial Transplant; 2013 Jul; 28(7):1830-8. PubMed ID: 23291369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanosensitive cation currents through TRPC6 and Piezo1 channels in human pulmonary arterial endothelial cells.
    Zhao T; Parmisano S; Soroureddin Z; Zhao M; Yung L; Thistlethwaite PA; Makino A; Yuan JX
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C959-C973. PubMed ID: 35968892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A common mechanism underlies stretch activation and receptor activation of TRPC6 channels.
    Spassova MA; Hewavitharana T; Xu W; Soboloff J; Gill DL
    Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16586-91. PubMed ID: 17056714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor-operated Ca2+ entry mediated by TRPC3/TRPC6 proteins in rat prostate smooth muscle (PS1) cell line.
    Thebault S; Zholos A; Enfissi A; Slomianny C; Dewailly E; Roudbaraki M; Parys J; Prevarskaya N
    J Cell Physiol; 2005 Jul; 204(1):320-8. PubMed ID: 15672411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosin light chain kinase-independent inhibition by ML-9 of murine TRPC6 channels expressed in HEK293 cells.
    Shi J; Takahashi S; Jin XH; Li YQ; Ito Y; Mori Y; Inoue R
    Br J Pharmacol; 2007 Sep; 152(1):122-31. PubMed ID: 17603544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N; Damodaran TV; Winn MP
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of Transient Receptor Potential Canonical Channel Activators Identifies Novel Neurotrophic Piperazine Compounds.
    Sawamura S; Hatano M; Takada Y; Hino K; Kawamura T; Tanikawa J; Nakagawa H; Hase H; Nakao A; Hirano M; Rotrattanadumrong R; Kiyonaka S; Mori MX; Nishida M; Hu Y; Inoue R; Nagata R; Mori Y
    Mol Pharmacol; 2016 Mar; 89(3):348-63. PubMed ID: 26733543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient receptor potential canonical 7: a diacylglycerol-activated non-selective cation channel.
    Zhang X; Trebak M
    Handb Exp Pharmacol; 2014; 222():189-204. PubMed ID: 24756707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes.
    Kim EY; Alvarez-Baron CP; Dryer SE
    Mol Pharmacol; 2009 Mar; 75(3):466-77. PubMed ID: 19052171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol suppresses angiotensin II-induced vasoconstriction via protein kinase A-mediated phosphorylation of the transient receptor potential canonical 6 channel.
    Nishioka K; Nishida M; Ariyoshi M; Jian Z; Saiki S; Hirano M; Nakaya M; Sato Y; Kita S; Iwamoto T; Hirano K; Inoue R; Kurose H
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2278-86. PubMed ID: 21799177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
    Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
    EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype.
    Gigante M; Caridi G; Montemurno E; Soccio M; d'Apolito M; Cerullo G; Aucella F; Schirinzi A; Emma F; Massella L; Messina G; De Palo T; Ranieri E; Ghiggeri GM; Gesualdo L
    Clin J Am Soc Nephrol; 2011 Jul; 6(7):1626-34. PubMed ID: 21734084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel TRPC6 mutation that causes childhood FSGS.
    Heeringa SF; Möller CC; Du J; Yue L; Hinkes B; Chernin G; Vlangos CN; Hoyer PF; Reiser J; Hildebrandt F
    PLoS One; 2009 Nov; 4(11):e7771. PubMed ID: 19936226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.